RecruitingNot applicableNCT05951751

The TRIple Elimination Model Of Mother-to-child Transmission Program (TRI-MOM)

Studying Congenital syphilis

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Institut de Recherche pour le Developpement
Principal Investigator: Sylvie Boyer, PhD
UMR 1252 SESSTIM
Intervention: TRI-MOM intervention(other)
Enrollment: 2800 enrolled
Eligibility: FEMALE
Timeline: 2024 – 2025

Study locations (2)

Centre Muraz/INSP, Bobo-Dioulasso, Burkina Faso
MRC The Gambia at LSHTM, Fajara, The Gambia

Collaborators

Centre Muraz · Medical Research Council · Institut Pasteur · REVS PLUS Burkina Faso · Young Gambian Mums Fund · National AIDS Control Program Gambia

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05951751 on ClinicalTrials.gov

Other trials for Congenital syphilis

Additional recruiting or active studies for the same condition.

RECRUITINGPHASE2NCT07189208
Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, Brazil
University of California, Los Angeles

See all trials for Congenital syphilis →

← Back to all trials